Daniel M. Wechsler has been appointed corporate vice president and global president of Bausch + Lomb’s Pharmaceuticals business. Mr. Wechsler assumes the role from Brent Saunders, who has been serving as interim global president of the business unit for the past several months. “Dan has a strong track record as a senior executive driving high performance in global health care companies,” said Brent Saunders, B+L’s chief executive officer. “His recruitment reflects our continuing progress towa...